Narcolepsy is a long-term brain condition that makes people feel extremely tired during the day and sometimes fall asleep suddenly, even when doing everyday things. Some people also have sudden muscle weakness (cataplexy), see dream-like images while awake, or feel unable to move as they fall asleep or wake up. Night-time sleep is often broken and restless. The next sections explain what causes narcolepsy, its symptoms, how it ’is diagnosed and treatment options.

What is narcolepsy?

Narcolepsy is a long-term brain (neurological) condition that disrupts the body’s natural sleep–wake control [1]. People with narcolepsy feel overwhelming daytime sleepiness and may have brief “sleep attacks” during everyday activities [1,2]. Some also have cataplexy, a sudden loss of muscle tone triggered by strong emotions like laughter [1,2]. Other common features are vivid dream-like hallucinations, sleep paralysis (being unable to move for a few seconds when falling asleep or waking), and broken sleep at night [2]. Although there is no cure, symptoms can usually be well managed with a personalised combination of medicines, planned naps, and practical safety steps [3,4].

What types of narcolepsies exist?

There are two main types [4-6] of narcolepsy. Type 1 includes cataplexy and is usually linked to low levels of hypocretin/orexin, a brain chemical that helps us stay awake [4]. Type 2 causes similar daytime sleepiness but does not include cataplexy and usually has normal hypocretin levels [4-6]. EDS is typically the first symptom to develop and cataplexy may appear later [2]. Both narcolepsy types can start in childhood, the teenage years, or early adulthood, and affect experiences at school and work; in relationships; and the ability to drive safely without proper support [3].

How common is it?

Estimates vary by study and country, but narcolepsy is considered uncommon [7]. European data suggest about 18–47 people per 100,000 are affected, with fewer than 1–2 new cases per 100,000 each year [7,8].

Symptoms

Narcolepsy can look different from person to person, but these are the symptoms most people experience:

  • Excessive daytime sleepiness (EDS). A strong, hard-to-resist urge to sleep during the day. These short, unplanned naps (“sleep attacks”) can happen at work, in class, or mid-conversation. People often feel briefly refreshed after a nap but get sleepy again shortly afterwards [1,2].
  • Cataplexy (in type 1 narcolepsy). Sudden loss of muscle tone (ranging from a drooping eyelid or weak knees to a brief collapse) triggered by strong emotions (often laughter, but also excitement, anger, or surprise). The person remains aware during an episode of cataplexy [1,2].
  • Sleep paralysis. For a few seconds up to a couple of minutes when falling asleep or waking, the person is awake but cannot move or speak [2].
  • Vivid dream-like hallucinations. Seeing or hearing things that aren’t there at the edge of sleep (as the person is drifting off or just waking). These hallucinations are common and relate to REM-sleep “dream” features spilling into wakefulness [2]. 

Other ways symptoms can show up day-to-day:

  • Automatic behaviours. Brief “micro-sleep” episodes during routine tasks (typing, writing, driving) where the person continues the activity but later doesn’t remember doing it well or safely [1,2]. 
  • Effects on thinking and mood. Trouble focusing, memory lapses, low energy, and mood symptoms can be reported and often improve when EDS is better managed [2].

Causes and risk factors

Narcolepsy happens when the brain’s sleep-wake control system is disrupted [2]. In Type 1 narcolepsy, this is usually because the cells that make hypocretin/orexin (a wake-promoting brain chemical) are not working properly, leading to very low or undetectable levels in spinal fluid [2]. In Type 2, hypocretin levels are usually normal and the exact cause is less clear [9].

Likely causes

  • Autoimmune process. Many people with Type 1 narcolepsy carry a specific immune-system gene marker (HLA-DQB1*06:02). This doesn’t cause narcolepsy by itself, but it raises susceptibility, suggesting the immune system may mistakenly target hypocretin-producing neurons [10,11]. 
  • Loss of hypocretin neurons in the hypothalamus (Type 1). This loss is what links most Type 1 cases to cataplexy and profound daytime sleepiness [2]. 
  • Injury, tumours, or inflammation. Much less commonly, narcolepsy-like symptoms can follow structural damage or disease affecting the hypothalamus (such as head trauma, certain infections, or rare inflammatory conditions). This is classified as secondary (symptomatic) narcolepsy [12].

Triggers or risk factors

  • Genetic predisposition. The HLA-DQB1*06:02 marker is common in Type 1 narcolepsy across ethnicities, but is also found in many people without narcolepsy; a positive test is not diagnostic and is used only in context with clinical findings [2,10,11]. 
  • Infections and immune activation. Prior streptococcal or influenza infections have been reported around the time symptoms begin in some people, supporting the theory that certain infections may trigger an immune response in those who are genetically predisposed [2,10,11].
  • Hormonal/life changes. Symptom onset often clusters around puberty or other major hormonal shifts; these are considered potential facilitators rather than direct causes [9]. 
  • Family history. Having a relative with narcolepsy slightly increases risk, but most cases are isolated [2].

Diagnosis

How narcolepsy is diagnosed

A sleep specialist confirms narcolepsy by reviewing a person’s medical history and symptoms together with targeted sleep testing. These tests assess the severity of daytime sleepiness, identify whether REM-sleep features are appearing at the wrong time, and rule out other possible causes. Typically, the clinician and patient will first review symptoms (such as daytime sleepiness, cataplexy-like events, vivid dreams or hallucinations, sleep paralysis, and night-time sleep quality) as well as any recent medications. The person experiencing such symptoms may be asked to keep a short sleep diary or wear a simple activity monitor for a week or two to show whether they are getting sufficient and regular sleep before testing [4,12,13]. 

The next step is an overnight sleep study to check for other sleep disorders and to prepare for the next-day nap study, which measures how quickly the person falls asleep and whether REM sleep appears too early [4,12,13]. If results are unclear, or if medication interferes with the tests, the assessments can be repeated [12]. 

In certain cases, a spinal-fluid (hypocretin/orexin) test is used to confirm the diagnosis, especially when cataplexy is uncertain or standard tests are hard to interpret [12].

Determining the Type

  • Type 1 narcolepsy: Daytime sleepiness plus cataplexy, or very low hypocretin/orexin levels on spinal-fluid testing [12].
  • Type 2 narcolepsy: Daytime sleepiness without cataplexy and with normal hypocretin/orexin levels. Some people initially labelled Type 2 are later reclassified if cataplexy appears [12].

What doctors must rule out

Before confirming narcolepsy, clinicians look for other causes of sleepiness or REM-like symptoms, such as chronic sleep deprivation, circadian-rhythm problems (shift work, jet lag), sedating medicines or substances, untreated obstructive sleep apnoea, major depression, and other central hypersomnias (e.g. idiopathic hypersomnia) [13].

Treatment and medication

Managing narcolepsy usually involves a combination of daily habits and medication. Treatment aims to improve daytime alertness, reduce REM-related symptoms, and help people function safely in daily life.

Non-pharmacological approaches

Establishing good routines can make medical treatment more effective. Keeping to a regular sleep schedule, planned short daytime naps, and paying attention to sleep hygiene can all improve alertness and reduce symptom severity. Treating other sleep conditions—such as sleep apnoea or restless sleep—and avoiding substances or medications that worsen sleepiness are also important [3,12].

Medication options

Medicines for narcolepsy fall into a few broad categories. Some help people stay awake by improving daytime alertness, while others reduce REM-related symptoms such as cataplexy, vivid dreams, or sleep paralysis by stabilising the sleep-wake cycle. A further group helps improve continuity of night-time sleep, which can indirectly reduce daytime sleepiness and enhance daily functioning [5,12]. Treatment plans are individualised, and most people benefit from combining behavioural strategies with one or more medication type.

Prevention

At present, narcolepsy cannot be prevented; treatments aim to manage symptoms and improve day-to-day functioning [2,4]. 

Practical strategies to manage symptoms:

  • Keep a regular sleep-wake schedule. Going to bed and waking up at consistent times helps stabilise alertness throughout the day [2]. 
  • Plan short daytime naps. One or two scheduled naps can temporarily boost alertness and reduce sleepiness “peaks” [2]. 
  • Optimise sleep hygiene. Create a quiet, dark sleep environment; limit late caffeine and alcohol intake; and adopt ‘wind down’ strategies before bed [2,14,15]. 
  • Safety first (work, school, driving). Align tasks with a person’s most alert times, schedule naps before long drives, and consider workplace/school accommodations to reduce risk [2,14-16]. 

Support mental health and education. Learning about narcolepsy, explaining symptoms and management protocols to family/teachers/employers, and seeking counselling when needed can improve quality of life and adherence to routines [2,15,17].

Scientific studies

Ongoing research is helping scientists better understand how the immune system may gradually target the brain cells that regulate wakefulness. This knowledge may in the future help doctors to identify narcolepsy earlier and even explore treatments that address the root cause, not just the symptoms [10,11]. Researchers are also looking closely at why narcolepsy sometimes appears in “clusters,” for example after certain infections or during particular seasons, to understand what triggers the condition in people who are already at higher risk [18]. 

At the same time, scientists studying brain cells and their communication networks—using both donated brain tissue and lab-grown cells—are learning how the loss of hypocretin-producing neurons disrupts normal sleep–wake control. This may inform future ways to restore or replace missing brain signals [19]. 

Diagnosis is also steadily improving, with new studies testing wearable devices to track sleep and activity patterns at home, giving a clearer picture of daily rhythms [20,21]. Studies are also focusing on real-life safety and functioning—such as how to support alertness while driving or working—as well as identifying narcolepsy sooner by combining lab data with everyday information [16,22].

This page is for general educational purposes only and is not a substitute for professional medical advice. If you think you may be in immediate danger (for example, falling asleep while driving), seek urgent help. Driving rules for people with narcolepsy vary by country—please check local regulations and consult your healthcare professional.

References:

  1. American Academy of Sleep Medicine. Narcolepsy [Internet]. Darien (IL): American Academy of Sleep Medicine [cited 2026 Jan 19]. Available from: https://aasm.org/resources/factsheets/narcolepsy.pdf.
  2. National Institute of Neurological Disorders and Stroke. Narcolepsy [Internet]. Bethesda (MD): National Institutes of Health; 2025 [cited 2026 Jan 19]. Available from: https://www.ninds.nih.gov/health-information/disorders/narcolepsy.
  3. Scammell TE. Treatment of narcolepsy in adults. In: UpToDate [Internet]. Waltham (MA): UpToDate Inc.; updated 2025 [cited 2026 Jan 19]. Available from: Treatment of narcolepsy in adults – UpToDate
  4. Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(9):1881–1893. 
  5. Ruoff C, Rye DB. The ICSD‑3 and DSM‑5 guidelines for diagnosing narcolepsy: clinical relevance and practicality. Curr Med Res Opin. 2016;32(10):1611–1622.
  6. Bassetti CLA, Kallweit U, Vignatelli L, Plazzi G, Lecendreux M, Baldin E, Dolenc-Groselj L, Jennum P, Khatami R, Manconi M, Mayer G, Partinen M, Pollmächer T, Reading P, Santamaria J, Sonka K, Dauvilliers Y, Lammers GJ. European guideline and expert statements on the management of narcolepsy in adults and children. J Sleep Res. 2021 Dec;30(6):e13387.
  7. Wang Y, Chen Y, Tong Y, et al. Heterogeneity in Estimates of Incidence and Prevalence of Narcolepsy: A Systematic Review and Meta-Regression Analysis. Neuroepidemiology. 2022;56(5):319–332.
  8. Kallweit U, Nilius G, Trümper D, et al. Prevalence, incidence, and health care utilization of patients with narcolepsy: a population-representative study. J Clin Sleep Med. 2022;18(6):1531–1537.
  9. Scammell TE. Clinical features and diagnosis of narcolepsy in adults. In: UpToDate [Internet]. Waltham (MA): UpToDate Inc.; updated 2025 [cited 2026 Jan 19]. Available from: https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-narcolepsy-in-adults
  10. Latorre D, Kallweit U, Armentani E, et al. T cells in patients with narcolepsy target self‑antigens of hypocretin neurons. Nature. 2018;562(7725):63‑68. 
  11. Kornum BR, Jennum P. The case for narcolepsy as an autoimmune disease. Expert Rev Clin Immunol. 2020;16(3):231‑233. 
  12. European Narcolepsy Network. How is narcolepsy diagnosed? [Internet]. Zürich (CH): EUNN; [cited 2026 Jan 19]. Available from: https://www.eu-nn.com/how-is-narcolepsy-diagnosed/
  13. Stanford Health Care. Narcolepsy: diagnosis [Internet]. Stanford (CA): Stanford Health Care; [cited 2026 Jan 19]. Available from: https://stanfordhealthcare.org/medical-conditions/sleep/narcolepsy/diagnosis.html
  14. Sleep Foundation. Narcolepsy treatments: behavioral approaches & medications [Internet]. [cited 2026 Jan 19]. Available from: https://www.sleepfoundation.org/narcolepsy/treatments
  15. National Sleep Foundation. Living with narcolepsy [Internet]. [cited 2026 Jan 19]. Available from: https://www.thensf.org/living-with-narcolepsy/ 
  16. McCall CA, Watson NF. Therapeutic strategies for mitigating driving risk in narcolepsy. Ther Clin Risk Manag. 2020;16:1099‑1108.
  17. Barker EC, Flygare J, Paruthi S, Sharkey KM. Living with narcolepsy: current management strategies, future prospects, and overlooked real-life concerns. Nature and Science of Sleep. 2020;12:453–466. doi:10.2147/NSS.S162762
  18. Gool JK, Schinkelshoek MS, Fronczek R. What triggered narcolepsy: H1N1 vaccination, virus, or both? Sleep. 2023;46(3):zsad005.
  19. Liblau RS, Vassalli A, Seifinejad A, Tafti M. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol. 2015;14(3):318‑328.
  20. Gnarra O, van der Meer J, Warncke JD, et al. SPHYNCS: feasibility of long‑term wearable monitoring and digital biomarkers in narcolepsy. Sleep. 2024;47(9):zsae083.
  21. Sameh A, Rostami M, Oussalah M, et al. Digital phenotypes and digital biomarkers using passive wearables and smartphones: systematic review. Artif Intell Rev. 2025;58:66.
  22. Johnson J, Diniz Araujo ML, Bena J, et al. Discrepancy between clinical phenotyping and ICSD‑3 criteria contributes to misdiagnosis in central disorders of hypersomnolence. Sleep. 2025;48(Suppl 1):A354–A355.
You might be interested in…

Alzheimer's

In 95% of cases, Alzheimer’s disease is the result of a combination of genetic, environmental and lifestyle factors that affect the person…

Alzheimer's

Alzheimer’s disease has many faces. Depending on the region that is affected, the symptoms will vary. Just as the manifestation of the…

Alzheimer's

The process of human aging is complex and yet not well understood. Our body changes with age and our brain too. There…